Search Results - "ALFANDARI, S"

Patterns of antibiotic use in hospital-acquired infections by Sevin, T., Daniau, C., Alfandari, S., Piednoir, E., Dumartin, C., Blanchard, H., Simon, L., Berger-Carbonne, A., Le Vu, S.

“…Monitoring the use of antimicrobials in hospitalized patients is critical owing to the risk of resistance selection. This study aimed to describe the patterns…”
Get full text

Carbapenems and febrile neutropenia by Alfandari, S., Berthon, C., Ader, F.

Get full text

Exogenous acquisition of Pseudomonas aeruginosa in intensive care units: a prospective multi-centre study (DYNAPYO study) by Coppry, M., Leroyer, C., Saly, M., Venier, A-G., Slekovec, C., Bertrand, X., Parer, S., Alfandari, S., Cambau, E., Megarbane, B., Lawrence, C., Clair, B., Lepape, A., Cassier, P., Trivier, D., Boyer, A., Boulestreau, H., Asselineau, J., Dubois, V., Thiébaut, R., Rogues, A-M.

“…Pseudomonas aeruginosa remains one of the most common nosocomial pathogens in intensive care units (ICUs). Although exogenous acquisition has been widely…”
Get full text

P1324: A RISK‐BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV‐POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION by Beauvais, D., Sourisseau, M., Béhal, H., Alfandari, S., Simon, N., Faure, E., Yakoub‐Agha, I.

Get full text

Application of guidelines for aminoglycosides use in French hospitals in 2013–2014 by Robert, J., Péan, Y., Alfandari, S., Bru, J.-P., Bedos, J.-P., Rabaud, C., Gauzit, R.

“…In 2011, the French Agency for Safety of Health Products issued guidelines underlining the principles of proper aminoglycosides’ use. The aim of the survey was…”
Get full text

Explicit definitions of potentially inappropriate prescriptions of antibiotics in hospitalized older patients by Baclet, N., Calafiore, M., Fregnac, C., Gavazzi, G., Forestier, E., Roubaud-Baudron, C., Fraisse, T., Alfandari, S., Senneville, E., Beuscart, J.-B.

“…•The use of explicit criteria for potentially inappropriate prescriptions (PIPs) increases the appropriateness of prescriptions.•Explicit definitions of…”
Get full text

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes by Bonnet, S., Duléry, R., Regany, K., Bouketouche, M., Magro, L., Coiteux, V., Alfandari, S., Berthon, C., Quesnel, B., Yakoub-Agha, I.

“…Antifungal prophylaxis (AP) has dramatically changed the epidemiology of invasive aspergillosis (IA). To better understand the differences in terms of clinical…”
Get full text

Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias by Delannoy, P.-Y., Boussekey, N., Devos, P., Alfandari, S., Turbelin, C., Chiche, A., Meybeck, A., Georges, H., Leroy, O.

“…Pharmacodynamic studies report on the rapid bactericidal activity of aminoglycosides, conferring them as being of theoretical interest for bacteraemia…”
Get full text

Factors associated with recurrence of catheter-related bloodstream infections in home parenteral nutrition patients by Béraud, G., Seguy, D., Alfandari, S., Lenne, X., Leburgue, F., Faure, K., Guery, B.

“…Blood cultures from outpatients receiving home parenteral nutrition (HPN) via long-term central venous access (CVA) were retrospectively analyzed from January…”
Get full text

French recommendations on control measures to reduce the infectious risk in immunocompromised patients by Zahar, J-R, Jolivet, S, Adam, H, Dananché, C, Lizon, J, Alfandari, S, Boulestreau, H, Baghdadi, N, Bay, J-O, Bénéteau, A-M, Bougnoux, M-E, Brenier-Pinchart, M-P, Dalle, J-H, Fournier, S, Fuzibet, J-G, Kauffmann-Lacroix, C, Le Guinche, I, Lepelletier, D, Loukili, N, Lory, A, Morvan, M, Oumedaly, R, Ribaud, P, Rohrlich, P, Vanhems, P, Aho, S, Vanjak, D, Gangneux, J-P

“…The increase use of immunosuppressive treatments in patients with solid cancer and/or inflammatory diseases requires revisiting our practices for the…”
Get full text

Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study by Venier, A.-G, Leroyer, C, Slekovec, C, Talon, D, Bertrand, X, Parer, S, Alfandari, S, Guerin, J.-M, Megarbane, B, Lawrence, C, Clair, B, Lepape, A, Perraud, M, Cassier, P, Trivier, D, Boyer, A, Dubois, V, Asselineau, J, Rogues, A.-M, Thiébaut, R

“…Summary Background Pseudomonas aeruginosa is a major nosocomial pathogen in intensive care units (ICUs); however, endogenous versus exogenous origin of…”
Get full text

Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology by des Champs-Bro, B., Leroy-Cotteau, A., Mazingue, F., Pasquier, F., François, N., Corm, S., Lemaitre, L., Poulain, D., Yakoub-Agha, I., Alfandari, S., Sendid, B.

“…Summary What is known and Objective:  Invasive fungal infections (IFI) are associated with high rates of morbidity and mortality, particularly in…”
Get full text

A prospective study of nosocomial-infection-related mortality assessed through mortality reviews in 14 hospitals in Northern France by Decoster, A, Grandbastien, B, Demory, M.-F, Leclercq, V, Alfandari, S

“…Summary Aim To determine the number of deaths associated with nosocomial infection (NI) occurring in French hospitals, and to evaluate the role of hospital…”
Get full text

Adult community-acquired bacterial meningitis requiring ICU admission: epidemiological data, prognosis factors and adherence to IDSA guidelines by Georges, H, Chiche, A, Alfandari, S, Devos, P, Boussekey, N, Leroy, O

“…Numerous guidelines are available to guide empirical antimicrobial therapy (EAT) in acute bacterial meningitis (ABM) patients. We analysed prognosis factors…”
Get full text

Dexamethasone in community-acquired pneumonia by Meybeck, A, Turbelin, C, Delannoy, PY, Olive, D, Alfandari, S

Get full text

A survey on the use of gentamicin in infective endocarditis by Béraud, G., Le Moal, G., Elsendoorn, A., Tattevin, P., Godet, C., Alfandari, S., Couet, W., Roblot, P., Roblot, F.

“…US and European guidelines recommend a daily divided gentamicin dose (3 mg/kg in two or three equally divided doses) for the treatment of infective…”
Get full text

Predisposing factors for nosocomial pneumonia in patients receiving mechanical ventilation and requiring tracheotomy by Georges, H, Leroy, O, Guery, B, Alfandari, S, Beaucaire, G

“…To assess the incidence of nosocomial pneumonia (NP) after tracheotomy in an ICU population and to determine NP risk factors during the ICU stay, particularly…”
Get more information

Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice by Aloy, B., Launay-Vacher, V., Bleibtreu, A., Bortolotti, P., Faure, E., Filali, A., Gauzit, R., Gilbert, M., Lesprit, P., Mahieu, R., Meyssonnier, V., Ogielska, M., Romaru, J., Salmon, D., Alfandari, S., Lemaignen, A.

“…•Dose adjustment of antibiotics prescribed to chronic kidney disease patients is a common problem in clinical practice. A working group of infectious disease…”
Get full text

Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens by Leroy, O, Giradie, P, Yazdanpanah, Y, Georges, H, Alfandari, S, Sanders, V, Devos, P, Beaucaire, G

“…Adequate antimicrobial therapy is a main approach employed to decrease the mortality associated with hospital-acquired pneumonia (HAP). All methods that…”
Get full text

An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients by Micol, JB, de Botton, S, Guieze, R, Coiteux, V, Darre, S, Dessein, R, Leroy, O, Yakoub-Agha, I, Quesnel, B, Bauters, F, Beaucaire, G, Alfandari, S

“…Service des Maladies du Sang, CHRU, Lille, France. We retrospectively identified an outbreak of 18 episodes of P. aeruginosa bacteriemia in 17 patients with…”
Get full text